SNY financial statements
The full income statement, balance sheet, and cash-flow statement for Sanofi ADS (SNY), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 38.1B+13.3% | 33.6B+7.3% | 31.4B+4.0% | 30.2B-5.3% | 31.8B+10.8% | ||
| Cost of revenue | 14.8B+3.3% | 14.3B+4.6% | 13.7B+9.3% | 12.5B-13.8% | 14.5B+4.6% | |
| Research & development | 8.87B+10.9% | 8.00B+13.7% | 7.04B+3.0% | 6.83B+1.5% | 6.73B+6.8% | |
| Operating income | 7.18B-8.5% | 7.85B+4.3% | 7.53B-29.5% | 10.7B+11.2% | 9.61B-40.3% | |
| Interest expense | 637M-45.1% | 1.16B-17.0% | 1.40B+209.3% | 452M+3.9% | 435M-1.6% | |
| Income tax | 1.18B-9.4% | 1.30B+18.4% | 1.10B-45.2% | 2.01B+8.9% | 1.84B-10.5% | |
| 8.88B+46.1% | 6.08B+3.4% | 5.88B-34.1% | 8.92B+20.1% | 7.43B-47.2% | ||
| Net income to common | 8.84B+46.9% | 6.02B+3.0% | 5.84B-33.6% | 8.80B+19.6% | 7.36B-47.5% | |
| $3.60+50.4% | $2.40+3.1% | $2.33-33.6% | $3.50 | — | ||
| EPS (basic) | $3.62+50.7% | $2.40+3.1% | $2.33-33.7% | $3.52 | — | |
| Weighted-avg shares (basic) | 2.44B-2.5% | 2.50B-0.0% | 2.50B-0.0% | 2.50B-0.0% | 2.50B-0.1% | |
| Weighted-avg shares (diluted) | 2.45B-2.4% | 2.51B-0.0% | 2.51B-0.0% | 2.51B+0.0% | 2.51B-0.3% | |
| Dividends per share | $2.22+9.0% | $2.03+5.7% | $1.93+10.0% | $1.75-7.5% | $1.89+5.4% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 36.4B-18.1% | 44.4B+30.8% | 33.9B-6.7% | 36.4B | — | ||
| Cash & equivalents | 8.99B+15.9% | 7.76B-19.5% | 9.64B-29.0% | 13.6B+18.4% | 11.5B-32.7% | |
| Inventory | 12.0B+22.0% | 9.84B-8.1% | 10.7B+12.0% | 9.55B-3.5% | 9.90B-3.3% | |
| 149B+7.5% | 139B-1.1% | 140B+3.6% | 135B-1.1% | 137B-2.6% | ||
| Property, plant & equipment | 11.8B+12.2% | 10.5B-6.4% | 11.2B+6.9% | 10.5B-7.6% | 11.4B-0.7% | |
| Goodwill | 48.5B+7.2% | 45.2B-17.3% | 54.7B+2.8% | 53.2B-2.6% | 54.6B+0.4% | |
| Total non-current assets | 113B+19.7% | 94.1B-11.3% | 106B+7.4% | 98.7B-3.0% | 102B+3.0% | |
| Total current liabilities | 33.3B+9.5% | 30.4B+13.5% | 26.8B+4.8% | 25.6B | — | |
| Long-term debt | 16.7B+36.1% | 12.3B-22.6% | 15.9B+0.3% | 15.8B-18.6% | 19.5B-19.6% | |
| 83.8B+3.7% | 80.8B-1.4% | 81.9B+2.8% | 79.7B+2.2% | 78.0B+0.9% | ||
| Total equity incl. non-controlling | 84.2B+3.7% | 81.2B-1.3% | 82.3B+2.7% | 80.1B+2.2% | 78.4B+1.2% | |
| Common shares issued | 2.44B | — | 2.53B+0.2% | 2.52B-0.2% | 2.53B+0.4% | |
| Shares outstanding (cover) | 2.44B-3.5% | 2.53B-0.1% | 2.53B+0.3% | 2.52B-0.2% | 2.53B+1.0% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Cash from operations | 12.2B+23.8% | 9.83B-11.4% | 11.1B+0.2% | 11.1B-11.1% | 12.4B+47.2% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt issued | 6.29B | 0.00-100.0% | 51.9M-96.8% | 1.63B | 0.00-100.0% | |
| Long-term debt repaid | 2.97B+308.0% | 727M-81.7% | 3.98B+39.4% | 2.86B+7.8% | 2.65B-41.2% | |
| Common stock issued | 200M-1.0% | 202M-4.1% | 211M+6.7% | 198M-10.2% | 220M-4.9% | |
| Common stock repurchased | 5.67B+1636.4% | 327M-49.0% | 641M+22.7% | 523M+15.6% | 452M-51.8% | |
| Dividends paid | 5.40B+6.1% | 5.09B+5.7% | 4.82B+9.9% | 4.38B-7.6% | 4.74B+5.6% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 118B-3.0% | 122B-2.8% | 125B+2.5% | 122B-3.3% | 127B+4.2% | |
| P/E | 13.3×-33.6% | 20.0×+42.6% | 14.1×-14.7% | 16.5×-3.3% | 17.0×+97.1% | |
| P/B | 1.4×-6.5% | 1.5×-4.2% | 1.6×+0.3% | 1.6×-3.3% | 1.6×+3.2% | |
| Earnings yield | 7.5%+50.6% | 5.0%-29.9% | 7.1%+17.2% | 6.1%+3.4% | 5.9%-49.3% | |
| Dividend yield | 4.6%+8.5% | 4.2%+9.0% | 3.9%+7.1% | 3.6%-4.3% | 3.8%+2.2% | |
| Source filing | 20-F | 20-F | 20-F | 20-F | 20-F |
About this data
Source: SNY’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all SNY filings on SEC EDGAR → Not investment advice.